rewirebio.iobenchmarks
Evidence claim

Section S4.1 states that the RFdiffusion arm is the published designs re-tested, not a rerun

Evaluation actor of Published RFdiffusion designs, re-synthesised and tested by the AlphaProteo authors

Section S4.1, verbatim: 'Published experimental success rates of RFdiffusion were based on 96-well biolayer interferometry (BLI) measurements [S28], which are impractical for us to perform on our own designs. Therefore, to quantitatively compare success rates, we downloaded sequences of the published RFdiffusion designs and synthesized and tested them by yeast display (Section S1.2) alongside our own designs. Our results matched the published success rates for PD-L1 but were 2-fold lower for IL-7RA (16% versus 33%) and 0% for TrkA (versus 6%) (Table S2). This is potentially due to differences between the yeast surface environment versus purified proteins, as well as our use of 10- to 20-fold lower target concentrations (0.5-1 uM versus 10 uM in [S28]), which may exclude lower-affinity hits.' Section S4.1 therefore states a shared assay and does not state a shared selection funnel: the AlphaProteo candidates were chosen by the authors' own filter from a larger in silico set, while the RFdiffusion candidates are the 95 designs the RFdiffusion authors published.

The AlphaProteo authors did not run RFdiffusion. Section S4.1 states that they downloaded the published RFdiffusion design sequences and synthesised and tested those by yeast display alongside their own designs, because the published RFdiffusion rates rest on 96-well BLI measurements that were impractical for them to perform.

Evidence

Source checking verifies the cited claim or transcription. It does not establish independent reproduction.

Evidence table

Inspect claims, sources and review details

Trace each statement to its source and review. A context-only reference supports the record generally; it does not verify an individual field. Source checking does not reproduce an experiment.

One row per statement and cited source. Multiple citations are not independent evaluations. Shared locators are labelled explicitly.

6 evidence rows matching the loaded filters

Claims, original sources and review scope · Release 2026-10-22-1b7cf027e4f6
Property and statementOriginal source and locationReview and provenance
Claimed field
evaluation_actor
Context-only references
De novo design of high-affinity protein binders with AlphaProteo (Zambaldi et al., arXiv 2024)

Original source ↗

Section S4.1

Version: arXiv version 1, posted 2024-09-12; full-text PDF (49 pages)
Retrieved: 2026-10-22T11:53:00Z

not individually reviewed

No individual claim review recorded

Source has a recorded evidence concern. Consult its source page before using the claim.

Audit details

Field: attributes.field

Source artifact SHA-256: 953b35644c0fa06ff090d7614c2e19525831f8fde50242e176d54474133c5a42

Hash scope: SHA-256 of one retrieval of the arXiv v1 PDF on 2026-10-22.

Inspected artifact

Source location
Section S4.1
Context-only references
De novo design of high-affinity protein binders with AlphaProteo (Zambaldi et al., arXiv 2024)

Original source ↗

Section S4.1

Version: arXiv version 1, posted 2024-09-12; full-text PDF (49 pages)
Retrieved: 2026-10-22T11:53:00Z

not individually reviewed

No individual claim review recorded

Source has a recorded evidence concern. Consult its source page before using the claim.

Audit details

Field: attributes.source_locator

Source artifact SHA-256: 953b35644c0fa06ff090d7614c2e19525831f8fde50242e176d54474133c5a42

Hash scope: SHA-256 of one retrieval of the arXiv v1 PDF on 2026-10-22.

Inspected artifact

Claimed value
Section S4.1, verbatim: 'Published experimental success rates of RFdiffusion were based on 96-well biolayer interferometry (BLI) measurements [S28], which are impractical for us to perform on our own designs. Therefore, to quantitatively compare success rates, we downloaded sequences of the published RFdiffusion designs and synthesized and tested them by yeast display (Section S1.2) alongside our own designs. Our results matched the published success rates for PD-L1 but were 2-fold lower for IL-7RA (16% versus 33%) and 0% for TrkA (versus 6%) (Table S2). This is potentially due to differences between the yeast surface environment versus purified proteins, as well as our use of 10- to 20-fold lower target concentrations (0.5-1 uM versus 10 uM in [S28]), which may exclude lower-affinity hits.' Section S4.1 therefore states a shared assay and does not state a shared selection funnel: the AlphaProteo candidates were chosen by the authors' own filter from a larger in silico set, while the RFdiffusion candidates are the 95 designs the RFdiffusion authors published.
Context-only references
De novo design of high-affinity protein binders with AlphaProteo (Zambaldi et al., arXiv 2024)

Original source ↗

Section S4.1

Version: arXiv version 1, posted 2024-09-12; full-text PDF (49 pages)
Retrieved: 2026-10-22T11:53:00Z

not individually reviewed

No individual claim review recorded

Source has a recorded evidence concern. Consult its source page before using the claim.

Audit details

Field: attributes.value

Source artifact SHA-256: 953b35644c0fa06ff090d7614c2e19525831f8fde50242e176d54474133c5a42

Hash scope: SHA-256 of one retrieval of the arXiv v1 PDF on 2026-10-22.

Inspected artifact

Description
The AlphaProteo authors did not run RFdiffusion. Section S4.1 states that they downloaded the published RFdiffusion design sequences and synthesised and tested those by yeast display alongside their own designs, because the published RFdiffusion rates rest on 96-well BLI measurements that were impractical for them to perform.
Context-only references
De novo design of high-affinity protein binders with AlphaProteo (Zambaldi et al., arXiv 2024)

Original source ↗

Section S4.1

Version: arXiv version 1, posted 2024-09-12; full-text PDF (49 pages)
Retrieved: 2026-10-22T11:53:00Z

not individually reviewed

No individual claim review recorded

Source has a recorded evidence concern. Consult its source page before using the claim.

Audit details

Field: description

Source artifact SHA-256: 953b35644c0fa06ff090d7614c2e19525831f8fde50242e176d54474133c5a42

Hash scope: SHA-256 of one retrieval of the arXiv v1 PDF on 2026-10-22.

Inspected artifact

Relationship: subject
uc-binder-20261022-config-rfdiffusion-published-designs-alphaproteo-yeast
Context-only references
De novo design of high-affinity protein binders with AlphaProteo (Zambaldi et al., arXiv 2024)

Original source ↗

Section S4.1

Version: arXiv version 1, posted 2024-09-12; full-text PDF (49 pages)
Retrieved: 2026-10-22T11:53:00Z

not individually reviewed

No individual claim review recorded

Source has a recorded evidence concern. Consult its source page before using the claim.

Audit details

Field: links:subject:uc-binder-20261022-config-rfdiffusion-published-designs-alphaproteo-yeast

Source artifact SHA-256: 953b35644c0fa06ff090d7614c2e19525831f8fde50242e176d54474133c5a42

Hash scope: SHA-256 of one retrieval of the arXiv v1 PDF on 2026-10-22.

Inspected artifact

Name
Section S4.1 states that the RFdiffusion arm is the published designs re-tested, not a rerun
Context-only references
De novo design of high-affinity protein binders with AlphaProteo (Zambaldi et al., arXiv 2024)

Original source ↗

Section S4.1

Version: arXiv version 1, posted 2024-09-12; full-text PDF (49 pages)
Retrieved: 2026-10-22T11:53:00Z

not individually reviewed

No individual claim review recorded

Source has a recorded evidence concern. Consult its source page before using the claim.

Audit details

Field: name

Source artifact SHA-256: 953b35644c0fa06ff090d7614c2e19525831f8fde50242e176d54474133c5a42

Hash scope: SHA-256 of one retrieval of the arXiv v1 PDF on 2026-10-22.

Inspected artifact

Sources and history

Release 2026-10-22-1b7cf027e4f6 · Record review: source checked

1 source record and release historyDownload this release (gzip)
Technical metadata and extraction receipts

Stable ID: uc-binder-20261022-claim-alphaproteo-s41-rfdiffusion-arm

field
evaluation_actor
review
artifact sha256: 953b35644c0fa06ff090d7614c2e19525831f8fde50242e176d54474133c5a42; method: source-hash-verification; independent-cell-check; ai-assisted-source-review; method note: Re-downloaded with curl (HTTP 200, 12,333,400 bytes) and the SHA-256 recomputed and matched. Own text layer made with pdftotext -layout (poppler 26.08.0), reproducing the extraction pass's 2,811 lines. Table 1, Table S2, Table S3 and Sections S1.2.1, S2, S4.1 and S4.2 read cell by cell and compared with every record. Column assignment re-derived arithmetically rather than trusted.; note: Reviewed in docs/reviews/use-cases/binder-2026-10-22.md. Automated AI review of the source transcription only; it is not human scientific review and nothing here was reproduced experimentally.; retrieval url: https://arxiv.org/pdf/2409.08022v1; reviewed at: 2026-10-22T15:00:00Z; reviewer: claude; reviewer note: Claude review agent, independent of the extraction agent; no human review claimed
source locator
Section S4.1
value
Section S4.1, verbatim: 'Published experimental success rates of RFdiffusion were based on 96-well biolayer interferometry (BLI) measurements [S28], which are impractical for us to perform on our own designs. Therefore, to quantitatively compare success rates, we downloaded sequences of the published RFdiffusion designs and synthesized and tested them by yeast display (Section S1.2) alongside our own designs. Our results matched the published success rates for PD-L1 but were 2-fold lower for IL-7RA (16% versus 33%) and 0% for TrkA (versus 6%) (Table S2). This is potentially due to differences between the yeast surface environment versus purified proteins, as well as our use of 10- to 20-fold lower target concentrations (0.5-1 uM versus 10 uM in [S28]), which may exclude lower-affinity hits.' Section S4.1 therefore states a shared assay and does not state a shared selection funnel: the AlphaProteo candidates were chosen by the authors' own filter from a larger in silico set, while the RFdiffusion candidates are the 95 designs the RFdiffusion authors published.
Related records

Suggest a correction